Many new fitness-tracking devices are on display at the Consumer Electronics Show in Las Vegas.
The DARPA-funded advance is designed to keep soldiers alive long enough to reach a hospital.
Presage’s device would allow oncologists to test potentially harmful compounds in tiny amounts before giving patients a full dose.
Portable diagnostic tools could offer a better outlook for TB patients.
Amgen and Genzyme are pursuing disruptive ways of making biological drugs.
In 2012, genomics tiptoed into the doctor’s office, gene therapy rose again, and man and machine united.
It’s hard to get straightforward health guidance from personal genome tests, which are banned in some places. But one way to make them more meaningful is to let more people buy them.
Proterro has received $3.5 million in funding to scale up its low-cost approach.
Devices from two startups could be used to treat people with anxiety disorders—and one of the devices may eventually diagnose pain.
With twice as many electrodes in her brain as previous study participants, a paralyzed woman can move a robotic arm with unprecedented flexibility.